acute need for better prevention and treatment strategies. Glucagon-like-peptide-1 (GLP-1), secreted from endocrine cells in the intestine upon meal intake, reduces food intake. We have previously ... shown that: Obese…
driving interest in gut hormone–based strategies for metabolic regulation. Glucagon-like peptide-1 (GLP-1) plays a central role in insulin secretion, appetite control, and postprandial glucose homeostasis. However…
GLP-1-based drugs have been proposed as a mono- or combined therapy for type 2 diabetes mellitus for the outstanding features, but natural GLP-1 is hardly used ... patients for frequent dosing. This study aims to…
Principles of Good Laboratory Practice (GLP) are a managerial quality control system covering the organisational process and the conditions under which non-clinical health and environmental studies are planned…
closely associated with impaired glucose metabolism and appetite dysregulation. Glucagon-Like Peptide-1 (GLP-1) is an important incretin hormone involved in insulin secretion and satiety control. Food-derived approaches…
This study aimed to investigate the stimulatory effect of glucagon-like peptide 1 (GLP-1) receptor agonist (GLP-1RA) on the apoptosis of hepatic stellate cells (HSCs) activated by high ... features were identified. HSC…
insufficient sensitivity and specificity for detection of hepatocellular carcinoma (HCC). Recently, glypican-3 (GLP-3) was suggested as a new biomarker for the detection HCC. Objectives: To determine the role ... serum…
regeneration. No current treatment achieves both goals in a clinical setting. The incretin hormone GLP-1 is effective in the treatment of type 2 diabetes (T2D), but not T1D. Recent ... provokes beta-cell apoptosis, such…
globe is marching towards perfection. Basically, GLP is a regulation not a guideline. Industry needs greater performance with minimum investments, which is possible only if you adopt GLP. Consumer focuses ... world, the…
address the possibility that genetic variation of GLP-1R gene could affect obesity according to the genotypes, we tried to detect the mutation/SNP in GLP-1R. In accordance with ... overweight/obese patients and 100…
Glucagon-like peptide-1 (GLP-1) is an incretin hormone derived from the transcription product of proglucagon gene and normalizes blood glucose by activating the GLP-1 receptor. However ... major pharmacological problem…
novel hypoglycemic agents- sodium glucose cotransporter 2 (SGLT2) (Dapagliflozin) or glucagon like peptide 1 (GLP-1) agonists (Liraglutide) on lipid profile. The aim of our observational study was to assess ... dietary…
diabetes have undesirable adverse effects of hypoglycemia and weight gain. Glucagon-like peptide-1 (GLP-1) receptor agonists represent a unique approach to the treatment of diabetes, with benefits extending…
food reward due to increased release of the anorexigenicincretin hormone glucagon-like peptide-1 (GLP-1) following RYGB that has been observed in both humans and rats. Despite growing evidence ... supporting this…
pharmacokinetic (PK) and toxicokinetic (TK) toxicology safety studies are performed using good laboratory practice (GLP) regulations to ensure the availability of safe medicines. International GLP regulations uniformly…
guarantee a better control of blood glucose levels. Incretins, especially glucagon-like peptide-1 (GLP-1), stimulate insulin secretion in a glucose-dependent manner. The incretin effect is thought ... Type 2 diabetes…
glucagon-like peptide-1 receptor (GLP-1R) is expressed in many tissues and has been implicated in diverse physiological functions, such as energy homeostasis and cognition. GLP-1 analogs ... type 2 diabetes and are…
Glucagon-like peptide-1 (GLP-1) and leptin are anorectic hormones produced in the small intestine and white adipose tissue, respectively. Investigating how these hormones act together as an integrated ... elucidate a…
complications such as heart attacks, blindness, amputations and kidney failure. Glucagon like Peptide-1 (GLP-1) is an effective insulinotropic agent and therefore its effects on insulin secretion have been ... secreted…
case of type 2 diabetes. Before the advent of SGLT-2 Inhibitors and GLP-1 Receptor Agonists (RA), there were hardly any benefits on cardiovascular mortality in the treatment ... older OAD. The SGLT-2 Inhibitors are…
important issue for better treatment of COPD patients. Glucagon like peptide-1 (GLP-1) is a gastrointestinal hormone and because of its pancreatic supporting function, GLP-1 receptor agonist ... clinically used as a…
important issue for better treatment of COPD patients. Glucagon-like peptide-1 (GLP-1) is a gastrointestinal hormone, and because of its pancreatic supporting function, GLP-1 receptor agonist ... clinically used as a…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.